Oncology Market
Oncology Market - Global Industry Assessment & Forecast
#
Pages:
145
Base Year:
2023
Jul - 2024
Format:
Report Code:
VMR-1883
Segments Covered
By
Cancer Diagnostics & Treatment Cancer Diagnostics, Cancer Treatment
-
By
Indication Lungs Cancer, Colorectal Cancer, Breast Cancer, Liver Cancer, Bladder Cancer, Head & Neck Cancer, Prostate Cancer, Other Indications
-
By
End Use Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Academia, Specialty Clinics, Other End Uses
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2023 |
| Forecast
Years:
|
2024 - 2032 |
 Historical
Years:
|
2018 - 2022 |
 Revenue
2023: |
USD 225.8 Billion |
 Revenue 2032:
|
USD 842.6 Billion |
 Revenue CAGR
(2024 - 2032): |
15.8% |
Fastest Growing Region (2024 -
2032)
|
Asia Pacific |
Largest Region (2023):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Oncology Market Segment Analysis
- Oncology Cancer Diagnostics & Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer Diagnostics
- Cancer Treatment
- Oncology Indication Outlook (Revenue, USD Million, 2018 - 2030)
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Oncology End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
-
Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
- North America
-
North America Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
-
North America Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
-
North America Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- U.S.
- U.S. Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- U.S. Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- U.S. Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- U.S. Oncology Market, by Cancer Diagnostics & Treatment
- Canada
- Canada Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Canada Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Canada Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Canada Oncology Market, by Cancer Diagnostics & Treatment
-
Mexico
- Mexico Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Mexico Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Mexico Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Mexico Oncology Market, by Cancer Diagnostics & Treatment
-
North America Oncology Market, by Cancer Diagnostics & Treatment
- Europe
-
Europe Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
-
Europe Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
-
Europe Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- U. K.
- U.K. Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- U.K. Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- U.K. Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- U.K. Oncology Market, by Cancer Diagnostics & Treatment
- France
- France Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- France Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- France Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- France Oncology Market, by Cancer Diagnostics & Treatment
-
Germany
- Germany Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Germany Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Germany Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Germany Oncology Market, by Cancer Diagnostics & Treatment
-
Italy
- Italy Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Italy Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Italy Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Italy Oncology Market, by Cancer Diagnostics & Treatment
-
Spain
- Spain Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Spain Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Spain Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Spain Oncology Market, by Cancer Diagnostics & Treatment
-
Rest of Europe
- Rest of Europe Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Rest of Europe Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Rest of Europe Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Rest of Europe Oncology Market, by Cancer Diagnostics & Treatment
-
Europe Oncology Market, by Cancer Diagnostics & Treatment
- Asia Pacific
-
Asia Pacific Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
-
Asia Pacific Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
-
Asia Pacific Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- China
- China Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- China Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- China Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- China Oncology Market, by Cancer Diagnostics & Treatment
- Japan
- Japan Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Japan Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Japan Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Japan Oncology Market, by Cancer Diagnostics & Treatment
-
Germany
- Germany Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Germany Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Germany Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Germany Oncology Market, by Cancer Diagnostics & Treatment
-
India
- India Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- India Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- India Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- India Oncology Market, by Cancer Diagnostics & Treatment
-
South Korea
- South Korea Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- South Korea Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- South Korea Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- South Korea Oncology Market, by Cancer Diagnostics & Treatment
-
South East Asia
- South East Asia Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- South East Asia Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- South East Asia Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- South East Asia Oncology Market, by Cancer Diagnostics & Treatment
-
Rest of Asia Pacific
- Rest of Asia Pacific Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Rest of Asia Pacific Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Rest of Asia Pacific Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Rest of Asia Pacific Oncology Market, by Cancer Diagnostics & Treatment
-
Asia Pacific Oncology Market, by Cancer Diagnostics & Treatment
- Latin America
-
Latin America Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
-
Latin America Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
-
Latin America Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Brazil
- Brazil Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Brazil Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Brazil Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Brazil Oncology Market, by Cancer Diagnostics & Treatment
- Argentina
- Argentina Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Argentina Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Argentina Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Argentina Oncology Market, by Cancer Diagnostics & Treatment
-
Rest of Latin America
- Rest of Latin America Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Rest of Latin America Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Rest of Latin America Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Rest of Latin America Oncology Market, by Cancer Diagnostics & Treatment
-
Latin America Oncology Market, by Cancer Diagnostics & Treatment
- Middle East & Africa
-
Middle East & Africa Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
-
Middle East & Africa Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
-
Middle East & Africa Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- GCC Countries
- GCC Countries Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- GCC Countries Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- GCC Countries Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- GCC Countries Oncology Market, by Cancer Diagnostics & Treatment
- South Africa
- South Africa Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- South Africa Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- South Africa Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- South Africa Oncology Market, by Cancer Diagnostics & Treatment
-
Rest of Middle East & Africa
- Rest of Middle East & Africa Oncology Market, by Cancer Diagnostics & Treatment
- Cancer Diagnostics
- Cancer Treatment
- Rest of Middle East & Africa Oncology Market, by Indication
- Lungs Cancer
- Colorectal Cancer
- Breast Cancer
- Liver Cancer
- Bladder Cancer
- Head & Neck Cancer
- Prostate Cancer
- Other Indications
- Rest of Middle East & Africa Oncology Market, by End Use
- Hospitals
- Diagnostic Laboratories
- Diagnostic Imaging Centers
- Academia
- Specialty Clinics
- Other End Uses
- Rest of Middle East & Africa Oncology Market, by Cancer Diagnostics & Treatment
-
Middle East & Africa Oncology Market, by Cancer Diagnostics & Treatment
- North America
Vantage Market
Research | 17-Nov-2022
FAQ
Frequently Asked Question
What is the global demand for Oncology in terms of revenue?
-
The global Oncology valued at USD 225.8 Billion in 2023 and is expected to reach USD 842.6 Billion in 2032 growing at a CAGR of 15.8%.
Which are the prominent players in the market?
-
The prominent players in the market are Ability Pharma, Thermo Fisher Scientific Inc., Abbvie Inc., Takeda Pharmaceutical Co. Ltd., Astrazeneca Plc., Pfizer Inc., Sysmex Corporation, Bayer Ag, Agilent Technologies Inc., Biogenex.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 15.8% between 2024 and 2032.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Oncology include
- The growing worldwide occurrence of most cancers is a pivotal factor shaping healthcare priorities, treatment strategies, and research endeavors aimed at preventing the growing burden of most cancers-related morbidity and mortality
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Oncology in 2023.
